About Us

We fund solutions that help men living with prostate cancer today.

​The PCF was created by a group of oncologists to invest in what we call “treatment innovation research.” This is a type of clinical research, that is research that is done using people as the research subject, not rats or cell lines. This research takes known treatment methods and innovates to produce breakthroughs for men within 4-6 years. Specifically, our aim is to achieve higher cure rates with fewer side effects. 

​Currently, only 3-4% of national prostate cancer funding is devoted to clinical research as a whole. This makes it almost impossible for talented clinicians to get funding for treatment innovation. PCF is the only organization in Canada dedicated to funding this kind of research. Men with prostate cancer live an average of 15 years before the disease begins to threaten their lives. Treatment innovation is the key to finding a cure for them rather than a possible new therapy for their sons courtesy of basic research.

---

We’re also on a mission to find “a cure without compromise.” 

A lot of men, when first diagnosed with prostate cancer, are more concerned about becoming impotent than they are about dying. And, as a consequence, too many decline to be treated. Unfortunately this is a very real threat. Historically, about 50% of men treated for prostate cancer suffer from erectile dysfunction. Our goal at PCF is to achieve higher cure rates with fewer side effects, so that men have a better chance at re-establishing their pre-treatment sexual function. In addition to reduced rates of erectile dysfunction, we have shown that reduced rates of urinary and bowel issues are possible. Our SABR Prostate Trial is a good example of research into a cure without compromise.

---

Meet our Directors

​The Prostate Cure Foundation is directed by a small group of professionals with special expertise and experience in prostate cancer. Their stewardship is turning today’s good ideas into tomorrow’s proven treatments. 

Dr. Andrew Loblaw, MD

Chair

Professor of Radiation Oncology,
University of Toronto

Clinician Scientist and GU site
Group Lead

Department of Radiation Oncology Sunnybrook Health Sciences Centre
 
EDUCATION
Doctor of Medicine 
Queen’s University
Kingston, Ontario

NAME

Title

Karen C Johnson

​TREASURER

Principal - Karen C Johnson Consulting
Senior Consultant to Pharmaceutical Industry

EDUCATION
Bachelor of Arts
Bachelor of Education 
St Thomas University Fredericton, New Brunswick
 
MBA Essentials
London School of Economics
​